Skip to main content
Fig. 3 | Journal of Cardiothoracic Surgery

Fig. 3

From: Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway

Fig. 3

DEX potentiates Nrf2 nuclear translocation and activates the Nrf2/GPX4 pathway. Nuclear Nrf2 expression and GPX4 expression were determined by Western blot. Three replicates were guaranteed in cell experiments. Mean ± standard deviation was introduced to represent data. The comparison among multiple groups was made using one-way analysis of variance with Tukey’s test. ** p < 0.01, *** p < 0.001

Back to article page